UPDATE: Jounce Therapeutics (JNCE) Tops Q3 EPS by 12c, Beats on Revenues; Lowers FY17 Revenue Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DGNX

Go back to UPDATE: Jounce Therapeutics (JNCE) Tops Q3 EPS by 12c, Beats on Revenues; Lowers FY17 Revenue Guidance Below Consensus
(NASDAQ: JNCE) Delayed: 1.88 --0 (-0%)
Previous Close $1.88    52 Week High $ 
Open $13.36    52 Week Low $ 
Day High $1.88    P/E N/A 
Day Low $1.88    EPS $ 
Volume 325,016